A5018774785- Traumatic Brain Injury and Neurovascular Disturbances
- Traumatic Brain Injury Research
- Health Systems, Economic Evaluations, Quality of Life
- Primary Care and Health Outcomes
- Neonatal Respiratory Health Research
- Mental Health and Patient Involvement
- Healthcare cost, quality, practices
- Anesthesia and Neurotoxicity Research
- Congenital Heart Disease Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Sepsis Diagnosis and Treatment
Mayo Clinic in Florida
2023-2025
Mayo Clinic
2023
Universidad de Especialidades Espíritu Santo
2022
Background: Chronic Kidney Disease (CKD) is a significant public health issue globally. Its progressive nature calls for innovative care models to mitigate disease progression and enhance patient outcomes. An interdisciplinary clinic model may offer comprehensive tailored the needs of CKD patients. The aim this study evaluate impact an on progression, healthcare utilization, social determinants (SDOH). Methods: We conducted retrospective cohort at Mayo Clinic in Rochester, Minnesota....
Traumatic brain injury (TBI) remains a major cause of morbidity and death among the pediatric population. Timely diagnosis, however, complex task because lack standardized methods that permit its accurate identification. The aim this study was to determine whether serum levels biomarkers can be used as diagnostic prognostic tool in pathology. This prospective, observational collected analyzed concentration neuronal at enrollment, 24h 48h post-injury, 34 children ages 0-18 with pTBI 19...
To evaluate the use of inflammasome signaling proteins, specifically ASC, in serum as a prognostic tool pediatric traumatic brain injury (pTBI).
Introduction: The aim of this study was to assess the utilization tau and phosphorylated at threonine 181 (p-tau181) residue as diagnostic prognostic neuronal blood-based biomarkers in setting mild moderate pediatric traumatic brain injury (pTBI) according Glasgow Coma Scale (GCS) Outcome Extended Pediatrics (GOS-E Peds). Methods: In prospective observational study, we included 29 patients aged 0-18 years who sustained a mild/moderate pTBI (GCS 9-15) 19 healthy controls (HC). Serum samples...
Introduction: This study aimed to determine if a serum biomarker panel can be used as diagnostic and prognostic tool in pediatric Traumatic Brain Injury (pTBI). Methods: Prospective, observational that collected analyzed brain injury biomarkers at enrollment, 24- 48-hours post-injury 34 children ages 0-18 with TBI 19 healthy controls (HC). Biomarkers included Glial Fibrillary Acidic Protein (GFAP), Neurofilament L (NfL), Ubiquitin-C-terminal Hydrolase (UCHL1), S100B, tau, p-tau181. Subjects...